Skip to main content
logo
Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
6.94
+0.15 (2.21%)
Feb 6, 2026, 4:00 PM EST - Market closed

Puma Biotechnology Revenue

Puma Biotechnology had revenue of $54.48M in the quarter ending September 30, 2025, a decrease of -32.36%. This brings the company's revenue in the last twelve months to $212.00M, down -12.96% year-over-year. In the year 2024, Puma Biotechnology had annual revenue of $230.47M, down -2.19%.

Revenue (ttm)
$212.00M
Revenue Growth
-12.96%
P/S Ratio
1.63
Revenue / Employee
$1,232,529
Employees
172
Market Cap
349.71M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024230.47M-5.17M-2.19%
Dec 31, 2023235.64M7.61M3.34%
Dec 31, 2022228.03M-25.12M-9.92%
Dec 31, 2021253.16M28.05M12.46%
Dec 31, 2020225.11M-47.15M-17.32%
Dec 31, 2019272.26M21.27M8.47%
Dec 31, 2018250.99M223.31M806.60%
Dec 31, 201727.69M--
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

PBYI News

More News